NOTE 4 - GOING CONCERN	3 Months Ended
NOTE 4 - GOING CONCERN	Sep. 30, 2015
Going Concern [Abstract]
Going Concern [Text Block]	NOTE 4 - GOING CONCERN The Company’s financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not established sufficient sources of revenue to cover its operating costs. The Company will engage in very limited activities until a source of funding is secured. The Company will offer noncash consideration and seek equity lines as a means of financing its operations. If the Company is unable to obtain revenue producing contracts or financing or if the revenue or financing it does obtain is insufficient to cover any operating losses it may incur, it may substantially curtail or terminate its operations or seek other business opportunities through strategic alliances, acquisitions or other arrangements that may dilute the interests of existing stockholders.

MJ Pharmaceuticals Inc. 10-Q